SMTL ID : 6h3k.1

Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enables the discovery of the Phase 1 clinical candidate BOS172722.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.48 Å

Oligo State

monomer

Ligands

1 x FMW: ~{N}8-(2,2-dimethylpropyl)-~{N}2-[2-ethoxy-4-(4-methyl-1,2,4-triazol-3-yl)phenyl]-6-methyl-pyrido[3,4-d]pyrimidine-2,8-diamine(Non-covalent)

FMW.1: 17 residues within 4Å: Chain A: I.16, V.24, Q.26, A.36, I.71, M.87, E.88, C.89, G.90, N.91, I.92, D.93, S.96, A.136, L.139, I.148, P.158 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.16, A:I.71, A:D.93, A:L.139, A:I.148, A:P.158 Hydrogen bonds: A:G.90, A:G.90, A:S.96

1 x 7PE: 2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHANOL(Non-functional Binders)

7PE.2: 7 residues within 4Å: Chain A: H.121, H.124, P.198, K.199, S.266, I.267, P.268 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:I.267

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Woodward, H.L. et al., Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4- d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4 H-1,2,4-triazol-3-yl)phenyl)-6-methyl- N8-neopentylpyrido[3,4- d]pyrimidine-2,8-diamine (BOS172722). J. Med. Chem. (2018)

Release Date

2018-09-19

Peptides

Dual specificity protein kinase TTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity protein kinase TTK

Related Entries With Identical Sequence